With a new, mid-cycle redistricting war raging in state after state, the media and politicians focus on which party is ...

Bio-Techne (TECH) is catching eyes ahead of its upcoming quarterly earnings, with recent buzz fueled by strong clinical data at SITC 2025 and the debut of new spatial biology tools. These developments ...

Missing Context in Single-Cell DataSingle-cell RNA sequencing has transformed biology by showing which genes are active in individual cells. However ...

ISLAMABAD: Experts at a seminar emphasized the need to transform the local automobile industry from “dependence ...

Understanding how cells communicate with each other to fuel diseases such as cancer is at the forefront of the newly created Hub for Advanced Spatial ...

AP Elections announced several new additions to the team as The Associated Press continues to strengthen and grow one of its core services. With a history ...

Q1 2026 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...

As climate change produces ever more heat waves, how many homes in the U.S. lack adequate cooling? Who's most vulnerable to ...

The AI BIO Conference 2025, an international conference exploring the future of medicine through the convergence of ...

Weather radar reveal a sharp divide across Britain, with nighttime insect flights dropping steeply while daytime numbers ...

What Happened: A notable Form 4 filing on Monday with the U.S. Securities and Exchange Commission revealed that Keegan, Board Member at Bio-Techne, exercised stock options for 0 shares of TECH, ...

EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an impressive EV/EBITDA ratio of 45.28, Bio-Techne demonstrates exemplary market ...